Pelthos Therapeutics (PTHS) Change in Cash (2023 - 2026)
Pelthos Therapeutics (PTHS) posted quarterly Change in Cash of $3.8 million for Q4 2025, up 608.09% year-over-year from $532421.0 in Q4 2024, and down 73.44% quarter-over-quarter from $14.2 million in Q3 2025.
Pelthos Therapeutics (PTHS) Change in Cash (2023 - 2026) Analysis & Trends
Pelthos Therapeutics' Change in Cash history runs 3 years deep, the most recent figure standing at $3.8 million for Q4 2025.
- In Q4 2025, Change in Cash rose 608.09% year-over-year to $3.8 million; the TTM figure through Dec 2025 stood at $17.5 million (up 4099.04% YoY), while the FY2025 annual figure was $17.5 million, up 4099.04% from the prior year.
- Change in Cash for Q4 2025 stood at $3.8 million, down from $14.2 million in the prior quarter.
- The five-year high for Change in Cash was $14.2 million in Q3 2025, with the low at -$1.4 million in Q2 2024.
- The 3-year median for Change in Cash is -$32786.5 (2023), against an average of $1.5 million.
- Peak annual rise in Change in Cash reached 56917.79% in 2024, while the deepest fall reached 4201.34% in 2024.
- Pelthos Therapeutics' Change in Cash stood at $73605.0 in 2023, then plunged by 1108.08% to -$742000.0 in 2024, then jumped by 608.09% to $3.8 million in 2025.
- Business Quant data shows PTHS's Change in Cash at $3.8 million in Q4 2025, $14.2 million in Q3 2025, and -$72145.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | Pelthos Therapeutics | 91.09 Mn | 66.53 Mn | 21.23 Mn | 6.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.54 Mn |
| Dec 31, 2025 | 3.77 Mn |
| Sep 30, 2025 | 14.19 Mn |
| Jun 30, 2025 | -72,145.00 |
| Mar 31, 2025 | -382,126.00 |
| Dec 31, 2024 | -742,000.00 |
| Sep 30, 2024 | -1.15 Mn |
| Jun 30, 2024 | -1.37 Mn |
| Mar 31, 2024 | 3.67 Mn |
| Dec 31, 2023 | 73,605.00 |
| Sep 30, 2023 | -59,107.00 |
| Jun 30, 2023 | 33,285.00 |
| Mar 31, 2023 | -6,466.00 |